Description:

Myasthenia Gravis is a neuro-muscular junction dysfunction that often presents to primary care optometry with variable ocular complaints.  This course reviews the ocular and systemic findings in myasthenia gravis and utilizes cases to emphasize how variable and nuanced these cases may present in office.  This course describes how inflammatory triggers including COVID-19 and the vaccine may cause complications and an increased incidence of myasthenia gravis, and the optometrist's role in co-management with neurology.

Course Code:

AOA293-SD

Speaker(s):

Jacqueline Theis, O.D.
dr.jaci.od@gmail.com

Credits:

1

AOA Expiration Date:

2/27/2025

Related News

What optometry’s advocates are championing at AOA on Capitol Hill

Learn about the priority federal issues that hundreds of optometrists and optometry students will take to Capitol Hill as part of optometry’s single-largest annual advocacy gathering, April 14-16, and how you can join.

Representation matters in optometry

Although about 13% of the U.S. population is Black, they are woefully underrepresented in optometry. They represent about 2% of practicing doctors of optometry and a little over 3% of full-time students in optometry schools and colleges, according to studies. Black doctors of optometry seek to grow those numbers.

Making blurry vision clear

February is Low Vision Awareness Month. Take note of considerations for enhancing success with near magnification.